Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review
Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports